Galectin Therapeutics reports Q1 EPS (19c) vs (19c) last year
PremiumThe FlyGalectin Therapeutics reports Q1 EPS (19c) vs (19c) last year
6M ago
Galectin Therapeutics says DSMB recommends continuation of NAVIGATE study
Premium
The Fly
Galectin Therapeutics says DSMB recommends continuation of NAVIGATE study
7M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
Galectin Therapeutics reports DSMB concludes NAVIGATE can continue as designed
PremiumThe FlyGalectin Therapeutics reports DSMB concludes NAVIGATE can continue as designed
1y ago
Galectin Therapeutics to present update on belapectin liver cirrhosis program
Premium
The Fly
Galectin Therapeutics to present update on belapectin liver cirrhosis program
1y ago
Galectin Therapeutics to present data on liver cirrhosis at NASH meeting
Premium
The Fly
Galectin Therapeutics to present data on liver cirrhosis at NASH meeting
1y ago
Galectin Therapeutics provides final randomization status of NAVIGATE
PremiumThe FlyGalectin Therapeutics provides final randomization status of NAVIGATE
2y ago
Galectin announces scientific paper used its Phase 2 biopsy material
Premium
The Fly
Galectin announces scientific paper used its Phase 2 biopsy material
2y ago
Galectin Therapeutics announces end of enrollment of NAVIGATE
Premium
The Fly
Galectin Therapeutics announces end of enrollment of NAVIGATE
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100